Halozyme Therapeutics (HALO) EPS (Basic) (2010 - 2026)
Halozyme Therapeutics (HALO) reported EPS (Basic) of $1.27 for Q1 2026, up 32.29% year-over-year from $0.96 in Q1 2025, and up 209.48% quarter-over-quarter from -$1.16 in Q4 2025.
Halozyme Therapeutics (HALO) EPS (Basic) (2010 - 2026) Analysis & Trends
Halozyme Therapeutics (HALO) has 17 years of EPS (Basic) data on file, last reported at $1.27 in Q1 2026.
- EPS (Basic) for Q1 2026 came in at $1.27, up 32.29% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.96 (down 23.12% YoY), and the FY2025 annual result was $2.64, down 24.57% from the prior year.
- EPS (Basic) improved to $1.27 in Q1 2026 per HALO's latest filing, from -$1.16 in the prior quarter.
- Over five years, EPS (Basic) peaked at $1.49 in Q3 2025 and troughed at -$1.16 in Q4 2025.
- A 5-year average of $0.65 and a median of $0.62 in 2023 frame the typical range for EPS (Basic).
- The sharpest annual moves came in 2023 and 2025: EPS (Basic) surged 256.25% in 2023, then plunged 207.41% in 2025.
- A 5-year view of EPS (Basic) shows it stood at $0.43 in 2022, then jumped by 51.16% to $0.65 in 2023, then jumped by 66.15% to $1.08 in 2024, then sank by 207.41% to -$1.16 in 2025, then soared by 209.48% to $1.27 in 2026.
- Business Quant data shows HALO's EPS (Basic) at $1.27 in Q1 2026, -$1.16 in Q4 2025, and $1.49 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | -0.68 |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | 3.06 |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | 0.00 |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | 0.00 |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | 0.00 |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | 0.00 |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 4.06 |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | -0.06 |
| 10 | Halozyme Therapeutics | 8.24 Bn | 7.92 Bn | 297.47 Mn | 1.27 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.27 |
| Dec 31, 2025 | -1.16 |
| Sep 30, 2025 | 1.49 |
| Jun 30, 2025 | 1.36 |
| Mar 31, 2025 | 0.96 |
| Dec 31, 2024 | 1.08 |
| Sep 30, 2024 | 1.08 |
| Jun 30, 2024 | 0.73 |
| Mar 31, 2024 | 0.61 |
| Dec 31, 2023 | 0.65 |
| Sep 30, 2023 | 0.62 |
| Jun 30, 2023 | 0.57 |
| Mar 31, 2023 | 0.29 |
| Dec 31, 2022 | 0.43 |
| Sep 30, 2022 | 0.45 |
| Jun 30, 2022 | 0.16 |
| Mar 31, 2022 | 0.44 |
| Dec 31, 2021 | 0.47 |
| Sep 30, 2021 | 1.53 |
| Jun 30, 2021 | 0.64 |